Melbourne, Sep 4, 2015 AEST (ABN Newswire) - Rhinomed Ltd (ASX:RNO) has been building its international presence and connections amongst the international investment and pharmaceutical community this year. In March, Michael Johnson was the keynote 'Rising Star' presentation at the Master Investor Show in London. The Show was attended by 4700 investors covering private investors, brokers, funds and analysts.

Rhinomed was invited to present at the conference by Jim Mellon, one of the UK's most successful investors. It was an excellent opportunity for Rhinomed to showcase its technology to an international audience.

Rhinomed's presentation titled 'Changing the way the world breathes' can be viewed on Youtube at:
http://www.youtube.com/watch?v=hNXqk-OiAbY

Rhinomed CEO, Michael Johnson, was joined on the stage by Rhinomed shareholder and brand ambassador, Sir Steve Redgrave, CBE - the 5 time consecutive Olympic gold medallist, who is recognised as one of the greatest Olympians of all time.

Sir Steve brings an incredible depth of experience in the importance of breathing in sport but also recovery for athletes. He also provided some insights into the difficulties of obtaining quality sleep when competing at the highest level.

BIO2015 in June

Rhinomed presented and exhibited at BIO2015 in Philadelphia in June - as part of the Victorian Government delegation. The conference is attended by over 15,000 industry professionals from around the globe and Rhinomed held back-back meetings across the program to discuss potential partnering and distribution opportunities.

Interbike 2015

Turbine will be exhibiting at Interbike 2015 in September this year. Interbike is the one-stop show to connect with all aspects of the entire bicycle industry, including products and latest trends. It includes both outdoor demonstration days and an indoor exhibition.

Turbine will be exhibiting and meeting with potential distributors and retailers from across the globe. "Interbike was incredibly successful at launching Turbine on the international stage last year and we are looking forward to building on this in 2015," Michael Johnson said.

To view the full newsletter and all updates, please visit:
http://media.abnnewswire.net/media/en/docs/ASX-RNO-429283.pdf


About Rhinomed Ltd

Rhinomed Limited ASX:RNO

Rhinomed Limited (ASX:RNO) is a Melbourne, Australia based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is developing and commercialising applications of its technology portfolio in the sport, sleep, cough/cold and allergy, and drug delivery markets. The company has two products in market (the Turbine for sports and exercise and Mute for snoring and better sleep) and has recently completed a pilot Phase I clinical trial of its new INPEAP technology targeting mild to moderate sleep apnea. For more information, go to www.rhinomed.global.

TwitterFollow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring

      


Contact

Rhinomed Ltd
Michael Johnson, CEO
T: +61-3-8416-0900
F: +61-3-8080-0796
E: mjohnson@rhinomed.com.au
WWW: www.rhinomed.com.au



Related Companies

Rhinomed Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 18) (Last 30 Days: 54) (Since Published: 2941) 
ANALYTICS: LOGIN HERE

Rhinomed Ltd NEWS: RECENT VISITS (3508)

Social Media